Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

Meta-analysis Global Group in Chronic Heart Failure (MAGGIC).

Eur Heart J. 2012 Jul;33(14):1750-7. doi: 10.1093/eurheartj/ehr254. Epub 2011 Aug 6. Review.

PMID:
21821849
2.

Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis.

Jackson CE, Castagno D, Maggioni AP, Køber L, Squire IB, Swedberg K, Andersson B, Richards AM, Bayes-Genis A, Tribouilloy C, Dobson J, Ariti CA, Poppe KK, Earle N, Whalley G, Pocock SJ, Doughty RN, McMurray JJ; Meta-Analysis Global Group in Chronic Heart Failure MAGGIC.

Eur Heart J. 2015 May 7;36(18):1106-14. doi: 10.1093/eurheartj/ehu490. Epub 2015 Jan 23. Review.

3.

[Heart failure with preserved ejection fraction: Diastolic heart failure].

Rutten FH, Cramer MJ, Paulus WJ.

Ned Tijdschr Geneeskd. 2012;156(45):A5315. Review. Dutch.

PMID:
23134752
4.

Outcomes in patients with heart failure with preserved ejection fraction.

Poppe KK, Doughty RN.

Heart Fail Clin. 2014 Jul;10(3):503-10. doi: 10.1016/j.hfc.2014.04.012. Review.

PMID:
24975912
5.

Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.

Hoong CW, Lim CP, Gao F, Chen Q, Kawa LB, Ching CK, Sim DK.

J Cardiovasc Med (Hagerstown). 2015 Sep;16(9):583-90. doi: 10.2459/JCM.0000000000000100. Review.

PMID:
25022929
6.

[Does treatment improve prognosis of heart failure with preserved ejection fraction?].

Schläpfer-Pessina A, Carballo S, Perrier A, Garin N.

Rev Med Suisse. 2015 Jan 21;11(458):199-205. Review. French.

PMID:
25831613
7.

Treatment of heart failure with preserved ejection fraction.

Barnes MM, Dorsch MP, Hummel SL, Koelling TM, Bleske BE.

Pharmacotherapy. 2011 Mar;31(3):312-31. doi: 10.1592/phco.31.3.312. Review.

8.

Advances in the treatment of heart failure with a preserved ejection fraction.

Das A, Abraham S, Deswal A.

Curr Opin Cardiol. 2008 May;23(3):233-40. doi: 10.1097/HCO.0b013e3282f73317. Review.

PMID:
18382212
9.
10.

Meta-analysis of Renin-Angiotensin-aldosterone blockade for heart failure in presence of preserved left ventricular function.

Meune C, Wahbi K, Duboc D, Weber S.

J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):368-75. doi: 10.1177/1074248410391667. Epub 2010 Dec 30. Review.

PMID:
21193681
11.

Clinical characteristics and outcomes of heart failure with preserved ejection fraction: lessons from epidemiological studies.

Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S.

J Cardiol. 2010 Jan;55(1):13-22. doi: 10.1016/j.jjcc.2009.09.003. Epub 2009 Nov 7. Review.

12.

Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis.

Adabag S, Roukoz H, Anand IS, Moss AJ.

J Am Coll Cardiol. 2011 Aug 23;58(9):935-41. doi: 10.1016/j.jacc.2011.05.022. Review.

13.

New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.

Senni M, Paulus WJ, Gavazzi A, Fraser AG, Díez J, Solomon SD, Smiseth OA, Guazzi M, Lam CS, Maggioni AP, Tschöpe C, Metra M, Hummel SL, Edelmann F, Ambrosio G, Stewart Coats AJ, Filippatos GS, Gheorghiade M, Anker SD, Levy D, Pfeffer MA, Stough WG, Pieske BM.

Eur Heart J. 2014 Oct 21;35(40):2797-815. doi: 10.1093/eurheartj/ehu204. Epub 2014 Aug 7. Review.

14.

A review of heart failure management in the elderly population.

Cheng JW, Nayar M.

Am J Geriatr Pharmacother. 2009 Oct;7(5):233-49. doi: 10.1016/j.amjopharm.2009.10.001. Review.

PMID:
19948300
15.

Hypertension as an underlying factor in heart failure with preserved ejection fraction.

Volpe M, McKelvie R, Drexler H.

J Clin Hypertens (Greenwich). 2010 Apr;12(4):277-83. doi: 10.1111/j.1751-7176.2009.00253.x. Review.

16.

Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials.

Ezekowitz JA, McAlister FA.

Eur Heart J. 2009 Feb;30(4):469-77. doi: 10.1093/eurheartj/ehn543. Epub 2008 Dec 9. Review.

PMID:
19066207
17.

Diastolic heart failure: predictors of mortality.

Sherazi S, Zaręba W.

Cardiol J. 2011;18(3):222-32. Review.

18.

Comorbidities and differential diagnosis in heart failure with preserved ejection fraction.

Campbell RT, McMurray JJ.

Heart Fail Clin. 2014 Jul;10(3):481-501. doi: 10.1016/j.hfc.2014.04.009. Review.

PMID:
24975911
19.

How do patients with heart failure with preserved ejection fraction die?

Chan MM, Lam CS.

Eur J Heart Fail. 2013 Jun;15(6):604-13. doi: 10.1093/eurjhf/hft062. Epub 2013 Apr 21. Review.

20.

Diabetes-related heart failure.

Bando YK, Murohara T.

Circ J. 2014;78(3):576-83. Epub 2014 Feb 6. Review.

Supplemental Content

Support Center